Novus coverage, page-6

Shane.hardy, you really need to do some serious research before opening your mouth.

I do not have to do anything to 'hold up a share price'. If the stock is good then the SP will look after itself., And if not, any amount of views that do not fit into your view of the world will not impact the SP.

The company you refer to is a $2b company - do you honestly believe I can hold up the SP -LOL. It's not a penny dreadful. Over the years I have been critical of them and management team at times. I post as I see it, and not for the benefit of TU's from others.

Having seen how long the process is from initial IDE or CE to creating a substantial business I genuinely have no fear of OSL being a threat at any time in the next 5 years. Although I am interested in the possibilities of using a different isotope to perform a similar or better outcome. That is why I did the research and published on HC, on depth of penetration in human tissue and the half life - which apparently most HC posters who hold, had not done. Pretty basic research I would have though for any investor in a new process / technology dealing with radiation in the human body?

I also know what it takes to get an IDE or a CE. So Mr smarty pants, pray tell us why the IDE that was in the final stages in late 2013, has yet to be granted. As an investor I assume you have researched the company in which you have placed your hard earned $ ??? or are you a short term Trader?

Now, back to my point. If OSL are going to get anywhere in HCC they will have to perform large clinical trials of several hundred Pts. In HCC they will have to at some point go head to head with sorafenib, or should SIRT get a good result next year, then head to head with SIRT using Y90.

Thus, I feel it would be better to follow through on the Pancreatic Ca, as there is less competition and is an 'easy' win if the process works. Due to the lack of an existing process that work to any great degree an HDE would be relatively easy.

This is just a logical extension of what SH should already know. I'm sorry that you feel that this is 'downramping'.

As a long term investor you should not be too concerned about short term fluctuations, assuming you are not trying to exit a bad position?

If my posts give cause for concern, then please use the moderation or ignore functionality as I have no desire to go to war with you. However should you decide that you wish to continue as you have done, then be warned I can be very tenacious, and I don't take prisoners

PS my main interest, leaving aside the technology , is that I see OSL as being a good fit for other said company as they have the marketing experience and over 700 centres worldwide using their product. A licensing deal would be the most likely outcome of hey are interested.